Alps Advisors Inc Seres Therapeutics, Inc. Transaction History

Alps Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $45,696 - $94,003	13,056 Added 23.86%	67,770 $435,000
Q2 2022 Aug 11, 2022	SELL	$2.7 - $7.62 $107,622 - $303,733	-39,860 Reduced 42.15%	54,714 $188,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $73,804 - $103,560	-11,715 Reduced 11.02%	94,574 $673,000
Q4 2021 Feb 09, 2022	SELL	$6.02 - $11.43 $36,872 - $70,008	-6,125 Reduced 5.45%	106,289 $885,000
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $41,152 - $170,336	-7,537 Reduced 6.28%	112,414 $782,000

Q2 2021 Aug 11, 2021	SELL	$18.46 - $24.36 $843,160 - $1.11 Million	-45,675 Reduced 27.58%	119,951 $2.86 Million
Q1 2021 May 07, 2021	BUY	$17.66 - $28.92 $272,370 - $446,033	15,423 Added 10.27%	165,626 $3.41 Million
Q4 2020 Feb 03, 2021	BUY	$23.25 - $37.73 $2.45 Million - $3.97 Million	105,292 Added 234.45%	150,203 $3.68 Million
Q2 2018 Jul 25, 2018	SELL	$6.91 - $9.55 $65,285 - $90,228	-9,448 Reduced 17.38%	44,911 $455,000
Q1 2018 May 01, 2018	BUY	$7.34 - $11.16 $69,348 - $105,439	9,448 Added 21.04%	54,359 $399,000
Q4 2017 Feb 05, 2018	BUY	$9.15 - $12.64 $45,868 - $63,364	5,013 Added 12.56%	44,911 $455,000
Q3 2017 Nov 03, 2017	BUY	$12.81 - $16.85 $511,093 - $672,281	39,898	39,898 $640,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.